BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
1-Year Return
36.47%
This Quarter Return
-18.82%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$1.03B
AUM Growth
-$231M
(-18%)
Cap. Flow
+$55.8M
Cap. Flow
% of AUM
5.42%
Top 10 Holdings %
Top 10 Hldgs %
74.22%
Holding
35
New
1
Increased
3
Reduced
–
Closed
1
Top Buys
| 1 |
Amylyx Pharmaceuticals
AMLX
|
+$35.4M |
| 2 |
TSVT
2seventy bio
TSVT
|
+$21M |
| 3 |
Mersana Therapeutics
MRSN
|
+$4.53M |
| 4 |
X4 Pharmaceuticals
XFOR
|
+$233K |
Top Sells
| 1 |
BLUE
bluebird bio
BLUE
|
+$5.38M |
Sector Composition
| 1 | Healthcare | 94.71% |
| 2 | Financials | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARYD
26
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $6.86M | 0.67% |
700,000
| – | – |
|
27
Spyre Therapeutics
SYRE
$945M
| $6.55M | 0.64% |
113,908
| – | – |
|
|
28
X4 Pharmaceuticals
XFOR
$73.2M
| $5.28M | 0.51% |
100,651
+4,433
| +5% | +$233K |
|
|
PANA
29
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
| $4.88M | 0.47% |
500,000
| – | – |
|
|
ARYE
30
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
| $4.86M | 0.47% |
500,000
| – | – |
|
|
BLSA
31
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $4.81M | 0.47% |
487,500
| – | – |
|
|
OMEG
32
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
| $3.93M | 0.38% |
400,000
| – | – |
|
|
FLACU
33
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
| $3M | 0.29% |
300,000
| – | – |
|
|
JYAC
34
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
| $2.95M | 0.29% |
300,000
| – | – |
|
|
BLUE
35
DELISTED
bluebird bio
BLUE
| – | – |
-26,909
| Closed | -$5.38M |
|